Press Releases XORTX Therapeutics Inc.

Equities

XRTX

CA98420Q3061

Market Closed - Toronto S.E. Other stock markets 03:59:59 2024-04-26 pm EDT			5-day change	1st Jan Change
4.07 ^CAD	+12.43%		0.00%	+40.34%

Apr. 22	XORTX Therapeutics Announces Publication of Key Research in ADPKD in Peer-reviewed Journal	MT
Apr. 08	XORTX Therapeutics Inc. Appoints Abigail Jenkins to the Board of Directors	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

XORTX Announces Publication of Key Research in ADPKD	Apr. 22	AQ
Money Talk Radio with Ellis Martin: XORTX Therapeutics Inc. (NASDAQ:XRTX) Dr. Allen Davidoff-Look for More M&As in the Kidney Disease Remediation Space in the Future	Apr. 21	AW
Money Talk Radio with Ellis Martin: XORTX Therapeutics Inc. (NAS:XRTX) (VAN:XRTX) Dr. Allen Davidoff-Look for More M&As in the Kidney Disease Remediation Space in the Future	Apr. 21	AQ
XORTX Welcomes New Member to the Board of Directors	Apr. 08	AQ
XORTX Announces Participation in Spring 2024 Investor Conferences	Apr. 08	AQ
XORTX Therapeutics : CONSOLIDATED FINANCIAL STATEMENTS - Form 6-K	Apr. 04	PU
XORTX Announces New Clinical Advisory Board Member	Mar. 28	AQ
XORTX Announces New Clinical Advisory Board Member	Mar. 27	AQ
XORTX: A Year of Milestones and Strategic Advancements as it Readies for a Registration Clinical Trial	Mar. 19	AQ
XORTX Highlights Achievements of 2023 and Preparation for Registration Clinical Trial	Mar. 19	AQ
XORTX Therapeutics : Investor Presentation	Mar. 05	PU
MONEY TALK RADIO with XORTX Therapeutics Inc. (NAS:XRTX) Dr. Allen Davidoff Explains Advanced Drug Therapy for Kidney Disease and Diabetes	Mar. 03	AQ
MONEY TALK RADIO with XORTX Therapeutics Inc. (NASDAQ:XRTX) Dr. Allen Davidoff Explains Advanced Drug Therapy for Kidney Disease and Diabetes	Mar. 03	AW
XORTX Files an Amended and Restated Prospectus Supplement for the Offering of Units	Feb. 01	GL
XORTX Announces $2 Million Public Offering	Jan. 16	AQ
XORTX Submits a New Patent for the Treatment of Chronic Kidney Disease	Jan. 03	AQ
XORTX Welcomes New Member to the Board of Directors	Jan. 02	AQ
XORTX Announces US ATM Offering	Nov. 30	AQ
XORTX Meets Nasdaq Continued Listing Requirements	Nov. 29	AQ
XORTX Clarifies Timing for Share Consolidation	Nov. 10	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases XORTX Therapeutics Inc.

Equities

XRTX

CA98420Q3061

Press Releases

Filters